"covid-19-drug"

The interim results on 353 patients showed that the drug has been successful in reducing viral load effectively with RT-PCR negativity.

The first result offering a safe, ready-to-use and cost-effective solution for Covid-19 treatment, Ertugliflozin is an FDA approved drug for type-2 diabetes.

Exploring newer options for the management of Covid-19 and similar infectious diseases with focus on antifungals

The drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of Defence Research and Development Organisation (DRDO).